BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14656418)

  • 1. How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.
    Kavaliotis J; Petridou S; Karabaxoglou D
    Int J Infect Dis; 2003 Dec; 7(4):274-7. PubMed ID: 14656418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial transmission of chickenpox and varicella zoster virus seroprevalence rate amongst healthcare workers in a teaching hospital in China.
    Yang J; Liu J; Xing F; Ye H; Dai G; Liu M; Lo SK; Lau RW; Chiu KH; Chan JF; Yuen KY
    BMC Infect Dis; 2019 Jul; 19(1):582. PubMed ID: 31277589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella zoster virus infection among healthcare workers in Taiwan: seroprevalence and predictive value of history of varicella infection.
    Wu MF; Yang YW; Lin WY; Chang CY; Soon MS; Liu CE
    J Hosp Infect; 2012 Feb; 80(2):162-7. PubMed ID: 22188630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
    Chazan B; Colodner R; Teitler N; Chen Y; Raz R
    Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
    Lafer MM; de Moraes-Pinto MI; Weckx LY
    Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia.
    Sam IC; Tariman H; Chan YF; Bador MK; Yusof MY; Hassan H
    Med J Malaysia; 2008 Dec; 63(5):429-30. PubMed ID: 19803311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
    Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
    BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella serology among school age children with a negative or uncertain history of chickenpox.
    Lieu TA; Black SB; Takahashi H; Ray P; Capra AM; Shinefield HR; Adler NE
    Pediatr Infect Dis J; 1998 Feb; 17(2):120-5. PubMed ID: 9493807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits.
    Dashraath P; Ong ES; Lee VJ
    Ann Acad Med Singap; 2007 Aug; 36(8):636-41. PubMed ID: 17767333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
    Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
    Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.
    Chang CK; Tan HF; Tseng HF; Lin CC
    Med Mal Infect; 2007 Apr; 37(4):222-8. PubMed ID: 17368781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
    Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
    Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
    Semenovitch I; Lupi O
    Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella seroprevalence in Turkish population in Cyprus.
    Kurugol Z; Koturoglu G; Aksit S; Ozacar T
    Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.